Literature DB >> 3276048

Loss of F1 hybrid resistance to bone marrow grafts after injection of parental lymphocytes. Demonstration of parental anti-F1 T killer cells and general immunosuppression in the host.

C Knobloch1, G Dennert.   

Abstract

B6D2F1 mice acutely reject parental C57Bl/6 bone marrow grafts, a phenomenon that is known as hybrid resistance. Injection of C57Bl/6 splenocytes into B6D2F1 recipients prior to bone marrow transplantation had previously been shown to facilitate growth of C57Bl/6 marrow grafts. We show in this report that for this effect to occur, radiation-sensitive T cells have to be present in the splenocyte inoculum. Loss of hybrid resistance following injection of C57Bl/6 splenocytes into B6D2F1 mice coincides with the appearance of T killer cells of C57Bl/6 origin that are specific for H-2 histocompatibility antigens of DBA/2. The parental T killer cells in unresponsive B6D2F1 mice express in vitro cytotoxic activity on H-2d targets and appear to be responsible for the acquired in vivo rejection of H-2d bone marrow grafts. Appearance of donor-derived T killer cells coincides with marked suppression of host immunity: lymphocytes from unresponsive B6D2F1 mice do not proliferate in mixed lymphocyte reactions and fail to respond to sheep erythrocytes in vitro, nor do they express natural killer (NK) activity. Concomitant with the suppression of NK activity, hybrid resistance to C57B1/6 marrow grafts disappears. This loss of resistance to bone marrow transplants is unspecific since third-party SJL marrow grafts are not rejected. It is concluded that suppression of hybrid resistance by injection of parental splenocytes into B6D2F1 mice is caused by a severe nonspecific suppression of host immune responsiveness by parental T cells that recognize disparate histocompatibility antigens in the host.

Entities:  

Mesh:

Year:  1988        PMID: 3276048     DOI: 10.1097/00007890-198801000-00037

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Evidence for differentiation of NK1+ cells into cytotoxic T cells during acute rejection of allogeneic bone marrow grafts.

Authors:  G Dennert; C Knobloch; S Sugawara; B Yankelevich
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

2.  Transplantation of multiple abdominal viscera.

Authors:  T E Starzl; M I Rowe; S Todo; R Jaffe; A Tzakis; A L Hoffman; C Esquivel; K A Porter; R Venkataramanan; L Makowka
Journal:  JAMA       Date:  1989-03-10       Impact factor: 56.272

3.  Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction.

Authors:  A M Mowat
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

4.  The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms.

Authors:  K Takeda; G Dennert
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

Review 5.  Treatment of graft-versus-host disease with naturally occurring T regulatory cells.

Authors:  Piotr Trzonkowski; Anna Dukat-Mazurek; Maria Bieniaszewska; Natalia Marek-Trzonkowska; Anita Dobyszuk; Jolanta Juścińska; Magdalena Dutka; Jolanta Myśliwska; Andrzej Hellmann
Journal:  BioDrugs       Date:  2013-12       Impact factor: 5.807

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.